Kingsview Wealth Management LLC acquired a new stake in HCA Healthcare, Inc. (NYSE:HCA – Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 1,891 shares of the company’s stock, valued at approximately $737,000.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in HCA. BlackRock Inc. purchased a new stake in HCA Healthcare in the second quarter valued at approximately $5,069,974,000. Norges Bank purchased a new position in shares of HCA Healthcare in the 4th quarter worth $1,262,513,000. Legal & General Group Plc purchased a new stake in HCA Healthcare during the second quarter valued at about $410,992,000. Jupiter Topco LLC purchased a new position in shares of HCA Healthcare in the 2nd quarter worth about $371,138,000. Finally, Life Cycle Investment Partners Ltd acquired a new stake in HCA Healthcare during the 4th quarter worth approximately $374,037,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.
HCA Healthcare Price Performance
Shares of HCA Healthcare stock opened at $417.57 on Monday. HCA Healthcare, Inc. has a 1-year low of $353.99 and a 1-year high of $556.52. The business has a 50-day moving average of $401.08 and a 200-day moving average of $441.07. The company has a market capitalization of $90.40 billion, a PE ratio of 13.98, a P/E/G ratio of 1.45 and a beta of 1.10.
HCA Healthcare Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be issued a $0.78 dividend. The ex-dividend date of this dividend is Wednesday, September 16th. This represents a $3.12 annualized dividend and a yield of 0.7%. HCA Healthcare’s dividend payout ratio is currently 10.45%.
Analysts Set New Price Targets
Several equities research analysts have issued reports on HCA shares. Argus decreased their price objective on shares of HCA Healthcare from $560.00 to $500.00 and set a “buy” rating for the company in a research note on Monday, May 4th. UBS Group reduced their target price on shares of HCA Healthcare from $635.00 to $579.00 and set a “buy” rating on the stock in a report on Monday, July 27th. Cantor Fitzgerald cut their price objective on HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating on the stock in a research report on Tuesday, July 7th. KeyCorp decreased their target price on HCA Healthcare from $475.00 to $435.00 and set an “overweight” rating for the company in a research report on Monday, July 27th. Finally, Barclays dropped their target price on HCA Healthcare from $402.00 to $387.00 and set an “equal weight” rating on the stock in a report on Monday, July 27th. Fourteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $462.64.
Read Our Latest Analysis on HCA
HCA Healthcare Company Profile
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Further Reading
- Five stocks we like better than HCA Healthcare
- Strike a Balance Between Growth and Stability With These 3 Names Ready to Rally
- Rubrik’s AI Security Bet Could Power the Next Leg Higher
- Apple’s Foldable iPhone Could Be a Catalyst, But Not a Cure-All
- Snowflake Is Up Nearly 50% in 2026—What Are Short Sellers Betting Against?
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
